Cargando…
A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolism
Only one out of 10 drugs in development passes clinical trials. Many fail because experimental animal models poorly predict human xenobiotic metabolism. Human liver chimeric mice are a step forward in this regard, as the human hepatocytes in chimeric livers generate human metabolites, but the remain...
Autores principales: | Barzi, Mercedes, Pankowicz, Francis P., Zorman, Barry, Liu, Xing, Legras, Xavier, Yang, Diane, Borowiak, Malgorzata, Bissig-Choisat, Beatrice, Sumazin, Pavel, Li, Feng, Bissig, Karl-Dimiter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489481/ https://www.ncbi.nlm.nih.gov/pubmed/28659616 http://dx.doi.org/10.1038/s41467-017-00049-x |
Ejemplares similares
-
Erratum: A novel humanized mouse lacking murine p450 oxidoreductase for studying human drug metabolism
por: Barzi, Mercedes, et al.
Publicado: (2017) -
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
por: Pankowicz, Francis P., et al.
Publicado: (2016) -
A human liver chimeric mouse model for non-alcoholic fatty liver disease
por: Bissig-Choisat, Beatrice, et al.
Publicado: (2021) -
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome
por: Kruse, Robert L., et al.
Publicado: (2021) -
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
por: Kruse, Robert L., et al.
Publicado: (2017)